ATE9803T1

7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them.

Abstract

This record has no abstract on file.

Term

Term ended

Projected expiry passed 21 August 2001, 25.1 years ago.

125 members in 28 offices

This recordMember, by publication datePriority claim18 more offices are in the list below

Priority claims1

Priority claims
Document	Office	Kind	Date
3033157	Germany	A	1980-09-03

Members125

Family members, oldest first
Document	Office	Kind
IE812032L	Ireland	L	1982-03-03
DK387781A	Denmark	A	1982-03-04
AU7468081A	Australia	A	1982-03-11
DE3033157A1	Germany	A1	1982-04-01
EP0049355A1	European Patent Office (EPO)	A1	1982-04-14
JPS5777683A	Japan	A	1982-05-15
FI822442A0	Finland	A0	1982-07-08
ES505138A0	Spain	A0	1982-08-16
ES8206523A1	Spain	A1	1982-08-16
ZA816080B	South Africa	B	1982-08-25
AR227063A1	Argentina	A1	1982-09-15
IL66243A0	Israel	A0	1982-11-30
IL66243D0	Israel	D0	1982-11-30
IE821606L	Ireland	L	1983-04-29
DK306082A	Denmark	A	1983-04-30
FI822442L	Finland	L	1983-04-30
NO822346L	Norway	L	1983-05-02
NO871195L	Norway	L	1983-05-02
AU8576882A	Australia	A	1983-05-05
JPS5874667A	Japan	A	1983-05-06
DE3142854A1	Germany	A1	1983-05-11
EP0078362A2	European Patent Office (EPO)	A2	1983-05-11
ZA824829B	South Africa	B	1983-05-25
ES516921A0	Spain	A0	1983-07-16
ES8307787A1	Spain	A1	1983-07-16
DD202560A5	German Democratic Republic (until 1990)	A5	1983-09-21
KR830007642A	Republic of Korea	A	1983-11-04
KR840000525A	Republic of Korea	A	1984-02-25
EP0078362A3	European Patent Office (EPO)	A3	1984-08-22
GR77707B	Greece	B	1984-09-25
EP0049355B1	European Patent Office (EPO)	B1	1984-10-10
AT9803T	Austria	T	1984-10-15
ATE9803T1This record	Austria	T1	1984-10-15
AU540242B2	Australia	B2	1984-11-08
DE3166619D1	Germany	D1	1984-11-15
NZ202278A	New Zealand	A	1985-02-28
KE3545A	Kenya	A	1985-07-19
HK61485A	Hong Kong, China	A	1985-08-23
PH18803A	Philippines	A	1985-09-27
CY1301A	Cyprus	A	1985-12-06
SG44685G	Singapore	G	1986-01-17
HU187580B	Hungary	B	1986-01-28
IL76998A0	Israel	A0	1986-04-29
IL76998D0	Israel	D0	1986-04-29
IL76999A0	Israel	A0	1986-04-29
IL76999D0	Israel	D0	1986-04-29
IL77000A0	Israel	A0	1986-04-29
IL77000D0	Israel	D0	1986-04-29
EP0078362B1	European Patent Office (EPO)	B1	1986-10-22
US4620007A	United States of America	A	1986-10-28
AT23040T	Austria	T	1986-11-15
ATE23040T1	Austria	T1	1986-11-15
DE3273892D1	Germany	D1	1986-11-27
IE51541B1	Ireland	B1	1987-01-07
CA1218067A	Canada	A	1987-02-17
IL80514A0	Israel	A0	1987-02-27
IL80514D0	Israel	D0	1987-02-27
KR870000441B1	Republic of Korea	B1	1987-03-10
NO871195D0	Norway	D0	1987-03-23
AU561103B2	Australia	B2	1987-04-30
KR870000895B1	Republic of Korea	B1	1987-05-02
US4670444A	United States of America	A	1987-06-02
JPS62161728A	Japan	A	1987-07-17
JPS62161763A	Japan	A	1987-07-17
AU7140687A	Australia	A	1987-07-30
AU7140587A	Australia	A	1987-08-06
IL66243A	Israel	A	1987-10-20
IL76998A	Israel	A	1987-10-20
IL76999A	Israel	A	1987-10-20
IL77000A	Israel	A	1987-10-20
IL80514A	Israel	A	1987-10-20
MY8700363A	Malaysia	A	1987-12-31
JPS6322057A	Japan	A	1988-01-29
JPS6322075A	Japan	A	1988-01-29
JPS6322076A	Japan	A	1988-01-29
NO158018B	Norway	B	1988-03-21
FI882335A	Finland	A	1988-05-18
FI882335A0	Finland	A0	1988-05-18
FI882335L	Finland	L	1988-05-18
AU573125B2	Australia	B2	1988-05-26
AU573126B2	Australia	B2	1988-05-26
CA1237431A	Canada	A	1988-05-31
NO158018C	Norway	C	1988-06-29
JPS6356224B2	Japan	B2	1988-11-07
FI885277A	Finland	A	1988-11-15
FI885277A0	Finland	A0	1988-11-15
FI885277L	Finland	L	1988-11-15
FI885278A	Finland	A	1988-11-15
FI885278A0	Finland	A0	1988-11-15
FI885278L	Finland	L	1988-11-15
JPS6362510B2	Japan	B2	1988-12-02
IE53709B1	Ireland	B1	1989-01-18
FI78689B	Finland	B	1989-05-31
FI78689C	Finland	C	1989-09-11
CA1272210A	Canada	A	1990-07-31
DK190890A	Denmark	A	1990-08-10
DK190890D0	Denmark	D0	1990-08-10
JPH0244827B2	Japan	B2	1990-10-05
JPH0314811B2	Japan	B2	1991-02-27
JPH0316344B2	Japan	B2	1991-03-05

Showing 100 of 125

7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them.

Abstract

Term

Priority claims1

Members125

Numbers

Titles2

Classification